ArticleAsian Pacific journal of cancer prevention : APJCP2025
Development of Nomogram for Predicting the Overall Survival of Diffuse Large B-Cell Lymphoma (DLBCL) Patients Based on Clinical Data and Systemic Inflammation Markers.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDiffuse large B-cell lymphoma (DLBCL) is the most prevalent non-Hodgkin lymphoma and an aggressive blood malignancy. Despite the development of prognostic factors for DLBCL across clinical and molecular aspects, the accessibility and affordability can vary, specifically in developing countries. Therefore, this study aimed to examine the systemic immune inflammation index (SII), a predictive factor for DLBCL and generated from basic blood data. The study also established an effective predictive nomogram by integrating clinicopathological factors to predict overall survival (OS).
methodsA retrospective analysis was carried out on the laboratory and clinicopathological data of DLBCL patients from January 2012 to December 2020 from the Division of Hematology and Medical Oncology, Department of Internal Medicine, Dr. Sardjito Hospital, Yogyakarta, Indonesia. Cox survival analyses, both univariate and multivariate, were used to find prognostic markers associated with OS. The dynamic nomogram was created using all independent prognostic variables.
resultsA total of 94 patients were included and based on the Akaike Information Criterion values from multivariate Cox analysis, absolute monocyte count (AMC), platelet count (PLT), platelet-to-lymphocytes ratio (PLR), and SII were independent prognostic factors of OS in DLBCL patients, and are included in the nomogram. The area under the curve in this group was 0.8, while the nomogram's C-index for predicting OS was 0.74.
conclusionThis study found that monocyte count, platelet count, PLR, and SII can predict OS in our study population of Indonesian DLBCL. Nomogram created from this findings is a new and potentially effective model for predicting OS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.